Bakirkoy Dr. Sadi Konuk Research and Training Hospital   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Istanbul Turkey (2000)

Organization Overview

First Clinical Trial
2010
NCT01957839
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

bakırköy Dr. Sadi Konuk Education hospital | Bakirkoy Dr. Sadi Konuk Research and Training Hospital | Bakırkoy Dr. Sadi Konuk Training and Research Hospital | Bakırkoy Dr.Sadi Konuk Training and Research Hospital, Pediatric Intensive Care Unit | Bakırköy Prof.Dr. Mazhar Osman Psychiatric and Neurological Diseases Hospital | Bakirkoy Sadi Konuk | Hediye Dagdeviren | Istanbul Bakirkoy Maternity and Children Diseases Hospital | SBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronavirus Infections (Phase 2)

Hemorrhage (Phase 4)

Multiple Organ Failure (Phase 2)

Pelvic Infection (Phase 4)

Pelvic Inflammatory Disease (Phase 4)

Pneumonia (Phase 2)

Postpartum Hemorrhage (Phase 4)

Severe Acute Respiratory Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 19
  • # of Trial APIs: 21